{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:09:55Z","timestamp":1773763795378,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.010","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T20:15:53Z","timestamp":1381522553000},"page":"985-992","source":"Crossref","is-referenced-by-count":55,"title":["Prevalence of Fabry Disease in Stroke Patients\u2014A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"given":"Qiyun","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitphapa","family":"Pongmoragot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Lanthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Saposnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in\u00a0Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","article-title":"Fabry's disease: alpha-galactosidase deficiency","volume":"167","author":"Kint","year":"1970","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib3","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","article-title":"Results of a nationwide screening for Anderson-Fabry disease among dialysis patients","volume":"15","author":"Kotanko","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1651-2227.2002.tb03104.x","article-title":"Cardiac involvement in Fabry disease","volume":"91","author":"Linhart","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib5","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00467-009-1353-0","article-title":"A case of minimal change disease in a Fabry patient","volume":"25","author":"Zarate","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1742-1241.2011.02695.x","article-title":"Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS)","volume":"65","author":"Barba-Romero","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","article-title":"Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease","volume":"417","author":"Elleder","year":"1990","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.2009.072116","article-title":"Screening for Fabry disease in high-risk populations: a systematic review","volume":"47","author":"Linthorst","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.clineuro.2007.03.008","article-title":"Middelheim Fabry Study (MIFAS): a retrospective Belgian study on\u00a0the prevalence of Fabry disease in young patients with cryptogenic stroke","volume":"109","author":"Brouns","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/STROKEAHA.109.570499","article-title":"Mutations of the GLA gene in young patients with stroke the PORTYSTROKE study\u2014screening genetic conditions in Portuguese young stroke patients","volume":"41","author":"Baptista","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/STROKEAHA.110.579409","article-title":"Belgian Fabry study:\u00a0prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease","volume":"41","author":"Brouns","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.10.005","article-title":"Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke","volume":"22","author":"Dubuc","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/STROKEAHA.112.663708","article-title":"Acute cerebrovascular disease in the young: the stroke in young Fabry patients study","volume":"44","author":"Rolfs","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1468-1331.2012.03737.x","article-title":"Zurich Fabry study\u2014prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA","volume":"19","author":"Sarikaya","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/STROKEAHA.109.558320","article-title":"Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke","volume":"41","author":"Wozniak","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1747-4949.2011.00734.x","article-title":"Fabry's disease: a prospective multicenter cohort study in young adults with cryptogenic stroke","volume":"7","author":"Saposnik","year":"2012","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/ebmh.1.2.37","article-title":"Guidelines for evaluating prevalence studies","volume":"1","author":"Boyle","year":"1998","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib22","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2008"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib23","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1468-1331.2012.03739.x","article-title":"Fabry disease in unselected patients with TIA or stroke: population-based study","volume":"19","author":"Marquardt","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib24","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel iii)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib25","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/archinte.160.9.1343","article-title":"Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis","volume":"160","author":"Valentine","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1378\/chest.06-1404","article-title":"Familial premature coronary artery disease mortality and obstructive sleep apnea","volume":"131","author":"Gami","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib27","article-title":"Premature risk of stroke associated with recency of immigration to Ontario","author":"Saposnik","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib28","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"Alpha galactosidase a deficiency: fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib29","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1212\/WNL.0b013e318270401d","article-title":"Age at stroke: temporal trends in stroke incidence in a large, biracial population","volume":"79","author":"Kissela","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCULATIONAHA.109.892497","article-title":"Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke","volume":"121","author":"Fonarow","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib31","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/STROKEAHA.107.511402","article-title":"Stroke outcome in those over 80: a multicenter cohort study across canada","volume":"39","author":"Saposnik","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib32","first-page":"209370","article-title":"Epidemiology and etiology of young stroke","volume":"2011","author":"Griffiths","year":"2011","journal-title":"Stroke Res Treat"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib33","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1161\/CIRCULATIONAHA.107.181486","volume":"115","author":"Adams","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib34","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1161\/STROKEAHA.109.551226","article-title":"Cardiac workup of ischemic stroke: can we improve our diagnostic yield?","volume":"40","author":"Morris","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2350-11-19","article-title":"Frequency of Fabry disease in male and female haemodialysis patients in Spain","volume":"11","author":"Gaspar","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib36","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J Am College Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib37","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/01.ASN.0000015236.70757.C4","article-title":"Biochemical and molecular genetic basis of Fabry disease","volume":"13","author":"Pastores","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/humu.9327","article-title":"Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease","volume":"25","author":"Schafer","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"issue":"Suppl 2","key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1023\/A:1012451320105","article-title":"Enzyme replacement therapy in Fabry disease","volume":"24","author":"Brady","year":"2001","journal-title":"J Inherit Metab Disease"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00004691-200212000-00011","article-title":"Small fiber dysfunction predominates in Fabry neuropathy","volume":"19","author":"Dutsch","year":"2002","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib42","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1523-1755.2004.00924.x","article-title":"Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta","volume":"66","author":"Linthorst","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","article-title":"Infusion of alpha-galactosidase a reduces tissue globotriaosylceramide storage in patients with Fabry disease","volume":"97","author":"Schiffmann","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Internal Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/joim.12077","article-title":"Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications","volume":"274","author":"Weidemann","year":"2013","journal-title":"J Int Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2013.08.010_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105230571300339X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105230571300339X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T14:18:25Z","timestamp":1564496305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105230571300339X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S105230571300339X"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2013.08.010","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}